ARTICLE | Discovery & Translation
NYU physician-scientist traces oxygen metabolism to pediatric disease breakthrough
Pacold’s Trailblazer Prize-winning research on hypoxic tumor metabolism yielded a therapy for a rare mitochondrial disease
August 25, 2026 11:52 PM UTC
Michael Pacold’s basic research into how cells survive extreme oxygen scarcity uncovered a previously unknown human metabolic pathway — and, within two years, a compassionate use treatment for a rapidly declining child.
Pacold, a New York University radiation oncologist and metabolism researcher, won the Paul-Gallin Trailblazer Prize for Physician-Scientists last month for turning a fundamental question about tumor metabolism into a therapy for a rare, fatal pediatric mitochondrial disease...
BCIQ Company Profiles